Clínica Universitaria Reina Fabiola

Córdoba X5004FHP

1 studies enrolling now · 9 studies all time

What they study most

Adenocarcinoma of Lung, Advanced Breast Cancer, Advanced or Metastatic Breast Cancer, Breast Cancer, Breast Neoplasms, Chemotherapy-Induced Nausea and Vomiting, Diabetes Mellitus, Type 2, Liposarcoma, Mesothelioma, Obesity, Overweight, Prostate Cancer

Studies at this site

• A Study of Macupatide (LY3532226) and Eloralintide (LY3841136), Alone or in Combination, in Adults With Obesity or Overweight and With Type 2 Diabetes — Recruiting now
• A Study to Learn About a New Medicine Called Vepdegestrant (ARV-471, PF-07850327) in People Who Have Advanced Metastatic Breast Cancer — Running, not enrolling
• A Study to Learn About the Study Medicine Called PF-07220060 in Combination With Fulvestrant in People With HR-positive, HER2-negative Advanced or Metastatic Breast Cancer Who Progressed After a Prior Line of Treatment — Running, not enrolling
• Study to Test the Safety and Tolerability of PF-07220060 in Participants With Advance Solid Tumors — Running, not enrolling
• A Study of Orforglipron in Adult Participants With Obesity or Overweight and Type 2 Diabetes — Completed
• Phase 3 Trial of Elacestrant Versus Standard of Care for the Treatment of ER+/HER2- Advanced Breast Cancer — Completed
• A Study to Learn About the Study Medicine (Called PF-07220060 in Combination With PF-07104091) In Participants With Breast Cancer and Solid Tumors — Running, not enrolling
• An Efficacy and Safety Study of Oral and Intravenous Palonosetron for the Prevention of Nausea and Vomiting — Completed
• Nintedanib (BIBF 1120) in Mesothelioma — Stopped early